Development of multiple cutaneous immune-related adverse events among cancer patients after immune checkpoint blockade: Supplemental File

These files discuss additional methodological details and include two supplemental tables, the first summarizing cirAE characteristics in patients who developed multiple cirAEs after ICI therapy, and the second describing demographic and baseline clinical characteristics of all patients.